PpProf. Peptide
← Back to Supplement Library

Ashwagandha

Growth Hormone Support

Last reviewed: May 26, 2026

Also Known As: Withania somnifera, Indian ginseng, winter cherry, KSM-66 (Ixoreal branded), Sensoril (Natreon branded), Shoden, ashwagandha

Supplement Class: Ayurvedic adaptogenic herb / HPA axis modulator / cortisol reducer / GABA-mimetic + thyroid-modulating triterpenoid lactones (withanolides)

Evidence Tier: Strong (cortisol reduction, stress, anxiety, sleep, resistance-training strength) — Chandrasekhar 2012, Lopresti 2019, Wankhede 2015, Ziegenfuss 2018 STAR trial, Salve 2019, Pratte 2014 systematic review. Moderate (testosterone elevation) — real in stressed/training/sleep-disrupted populations via cortisol-suppression relief; smaller effect in young replete untrained men. Deep evidence base (50+ human RCTs) — one of the better-supported adaptogens.

What is ashwagandha?

Ashwagandha (Withania somnifera) is one of the most important herbs in Ayurvedic medicine — used for 3,000+ years as a rasayana (rejuvenating tonic) for stress resilience, vitality, and longevity. It is classified as an adaptogen — a natural compound that helps the body normalize its response to stressors. The primary bioactive compounds, withanolides (triterpenoid lactones), modulate the HPA axis to reduce chronic cortisol elevation, with downstream effects on testosterone preservation (relieving cortisol-mediated suppression), sleep architecture (cortisol reduction + GABA-mimetic activity), strength and recovery (Wankhede 2015 KSM-66 +18.2 kg bench press vs +6.1 kg placebo), and anxiety. The evidence base is one of the deeper in the adaptogen space — 50+ human RCTs across stress, cortisol, testosterone, strength, sleep, anxiety, and thyroid endpoints. Foundational trials: Chandrasekhar 2012 (cortisol -27.9%, stress -44%), Wankhede 2015 (KSM-66 testosterone and strength), Lopresti 2019 (Shoden cortisol replication), Salve 2019 (sleep PSQI), Ziegenfuss 2018 STAR (Sensoril strength). The testosterone effect is real but context-dependent — works in stressed, training-loaded, sleep-disrupted, or hypogonadal populations where cortisol is the limiting factor; smaller in young replete untrained men. This is meaningfully different from ZMA, where the testosterone claim has been refuted in replete athletes. Ashwagandha pairs naturally with GH-axis peptides like CJC-1295 and Ipamorelin — audit pairing #3, one of the highest-leverage bidirectional cross-links in the wave spec.

Reported benefits:

  • Significant cortisol reduction (~22–28% across trials) and stress relief (Chandrasekhar 2012, Lopresti 2019)
  • Testosterone elevation in stressed/training-loaded populations (Wankhede 2015 +96 ng/dL with KSM-66 in resistance-trained men)
  • Resistance-training strength gains (+18.2 kg bench press vs placebo; Wankhede 2015, Ziegenfuss 2018)
  • Improved sleep quality on PSQI (Salve 2019, 60-day KSM-66 trial)
  • Anxiety reduction comparable to some prescription anxiolytics in mild-moderate cases
  • Thyroid hormone elevation (T4, T3) in subclinical hypothyroidism (Sharma 2018)
  • Improved VO2 max and cardiorespiratory endurance
  • Male fertility improvements (sperm count, motility, morphology)

Common dose: 600 mg/day total of KSM-66 or Sensoril standardized extract — typically 300 mg twice daily (AM + PM) or 600 mg evening for sleep-focused protocols. Wankhede 2015 testosterone/strength protocol: 300 mg KSM-66 twice daily. Salve 2019 sleep protocol: 600 mg KSM-66 evening. With food preferred for better tolerance.

Watch for: Thyroid hormone elevation (avoid in hyperthyroidism; coordinate with endocrinologist if on thyroid medication); rare liver injury reports at very high doses (1,500+ mg/day) — stay within 600 mg/day for chronic use; pregnancy contraindication (traditional uterine-stimulant use); nightshade-family allergy possible.

Shop Ashwagandha on Amazon →

How does ashwagandha work?

Ashwagandha works primarily through HPA-axis modulation — withanolides (the active triterpenoid lactones) reduce chronic cortisol elevation by normalizing the hypothalamic-pituitary-adrenal stress response. This cortisol reduction has downstream effects on testosterone preservation, sleep architecture, and recovery. Secondary mechanisms include GABA-mimetic activity and thyroid hormone modulation.

  1. HPA axis modulation and cortisol reduction. Withanolides modulate the hypothalamic-pituitary-adrenal axis, reducing excessive cortisol secretion in chronically stressed individuals. Chandrasekhar 2012 documented 27.9% cortisol reduction with KSM-66; Lopresti 2019 documented 22.2% reduction with Shoden extract. The cortisol-reduction mechanism is the central effect that drives most other documented benefits.
  2. Testosterone preservation via cortisol-suppression relief. Chronically elevated cortisol suppresses testosterone production via multiple mechanisms (LH suppression, direct Leydig cell effects, SHBG modulation). Ashwagandha's cortisol reduction relieves this suppression in cortisol-stressed populations — producing the testosterone elevation documented by Wankhede 2015 (KSM-66 in resistance-trained men) and Lopresti 2019 (in overweight adults). Effect is mechanistically real but context-dependent: most useful when cortisol is the limiting factor for testosterone.
  3. GABA receptor agonism. Withanolides bind GABA receptors, producing anxiolytic and sleep-promoting effects without the dependence risk of benzodiazepines. This mechanism supports the sleep-architecture-improvement effects documented in Salve 2019 (PSQI improvement at 600 mg/day for 60 days).
  4. Thyroid hormone modulation. Sharma 2018 documented ashwagandha modestly raises T4 and T3 in subclinical hypothyroidism populations. Mechanism may involve withanolide effects on thyroid peroxidase activity or pituitary TSH dynamics. Clinically relevant for users with subclinical hypothyroidism; potentially problematic for hyperthyroid or thyroid-medicated users.
  5. Antioxidant and anti-inflammatory effects. Withanolides reduce oxidative stress and inflammatory cytokine production. Mechanism is secondary to the HPA arm but contributes to the broader recovery and longevity-relevant effect profile.
  6. Sleep architecture support. Beyond GABA effects, ashwagandha's cortisol-reduction-mediated improvement in slow-wave sleep architecture is mechanistically important — chronic cortisol elevation degrades deep sleep, and the majority of nightly GH release occurs during slow-wave sleep. The sleep mechanism arm has substantial overlap with the GH-axis support framing.
  7. Anti-fatigue effects. Mechanistically distinct from Rhodiola — ashwagandha's anti-fatigue effect is calming-leaning (via cortisol reduction + GABA modulation) rather than stimulating (Rhodiola's MAO inhibition + monoamine preservation). The two adaptogens have complementary but distinct mechanism profiles.

What does ashwagandha actually do?

Ashwagandha has one of the deeper adaptogen evidence bases — 50+ human RCTs across stress, cortisol, testosterone, strength, sleep, anxiety, and thyroid endpoints. The cortisol and stress evidence is the most robust; the testosterone evidence is real but context-dependent (works in stressed/training/sleep-disrupted populations, smaller effect in young healthy untrained men); the sleep and strength evidence is moderate-to-strong.

  1. Cortisol reduction and stress (Strong). Chandrasekhar 2012 (KSM-66, n=64, 60 days) documented 27.9% cortisol reduction and 44% perceived stress reduction. Lopresti 2019 (Shoden, n=60, 8 weeks) replicated with 22.2% cortisol reduction. Multiple subsequent trials confirm the cortisol-and-stress arm across extracts and populations.
  2. Testosterone elevation in context-specific populations (Moderate). Wankhede 2015 (KSM-66 in resistance-trained men) documented +96 ng/dL testosterone vs +18 placebo over 8 weeks. Lopresti 2019 documented testosterone and DHEA-S increases in overweight men aged 40–70. Mechanism is cortisol-suppression-relief — effect is real in stressed, training-loaded, sleep-disrupted, or hypogonadal populations; smaller in young replete untrained men. Not equivalent to TRT.
  3. Sleep quality (Moderate-Strong). Salve 2019 (600 mg KSM-66, 60 days) documented significant PSQI improvement in adults with insomnia. Sleep effects are real and clinically meaningful; build over 2–4 weeks of evening dosing.
  4. Resistance training strength and recovery (Strong). Wankhede 2015 (+18.2 kg bench press vs +6.1 kg placebo) and Ziegenfuss 2018 STAR trial (Sensoril, 12 weeks, significant strength and recovery improvements) provide strong evidence for the strength-training-adjunct use case across different branded extracts.
  5. Anxiety reduction (Strong). Multiple RCTs (Chandrasekhar 2012, Lopresti 2019, Pratte 2014 systematic review) document significant anxiety score reductions. Effect comparable to some prescription anxiolytics in mild-to-moderate generalized anxiety.
  6. Cardiorespiratory endurance (Moderate). A 2020 trial documented 13% VO2 max improvement vs 7% placebo over 8 weeks in healthy adults. Mechanism likely involves cortisol-reduction-mediated improvements in adaptive capacity and energy metabolism.
  7. Subclinical hypothyroidism (Moderate). Sharma 2018 documented significant T4 and T3 increases with ashwagandha in subclinical hypothyroid patients. Useful in this specific population; problematic if combined with thyroid medication.
  8. Cognitive function (Modest). Some trials document modest cognitive improvements in older adults and stressed populations. Effect is smaller than the cortisol/stress/sleep arms; the cognitive case is secondary.
  9. Male fertility (Moderate). Several trials in infertile or subfertile men document improvements in sperm count, motility, and morphology with ashwagandha supplementation. Useful adjunct in male fertility contexts.

How is ashwagandha dosed?

Ashwagandha dosing is well-characterized from a deep trial base. Standard range: 300–600 mg/day of standardized extract (KSM-66 5% withanolides or Sensoril 10% withanolides). For testosterone/strength: 300 mg KSM-66 twice daily (Wankhede protocol). For sleep: 600 mg KSM-66 evening dose (Salve protocol). For stress/anxiety: 600 mg/day split AM/PM.

  1. Stress and cortisol reduction. 600 mg KSM-66/day (300 mg twice daily) — the Chandrasekhar 2012 protocol. Effect builds over 4–8 weeks.
  2. Testosterone and strength training. 300 mg KSM-66 twice daily — the Wankhede 2015 protocol. Pair with consistent resistance training for the strength gains.
  3. Sleep quality. 600 mg KSM-66 evening dose — the Salve 2019 sleep trial protocol. Evening-only dosing leverages the cortisol-reduction effect at the bedtime cortisol-rise window.
  4. Sensoril alternative. 240–500 mg/day Sensoril (root + leaf, 10% withanolides). Stronger cortisol-reduction effect; root + leaf composition has slight liver-signal concern in some case reports.
  5. Upper bound. 1,000 mg/day extract — above this, side effects (drowsiness, GI, rare liver signal) scale faster than benefits. Stay within 600 mg/day for chronic use unless under medical supervision.

Timeline: anxiety/stress effects emerge over 2–4 weeks; sleep effects 2–4 weeks; testosterone/strength effects 6–8 weeks; chronic cortisol normalization over 8–12 weeks. Don't evaluate before 4 weeks of consistent use.

Label math. Look for “KSM-66” (Ixoreal Biomed, root-only, 5% withanolides) or “Sensoril” (Natreon, root + leaf, 10% withanolides) explicitly. Generic “ashwagandha extract 600 mg” without standardization disclosure may contain 1–3% withanolides at variable purity — meaningfully different from the branded extracts used in clinical trials.

How to take ashwagandha

Ashwagandha is taken orally as capsules of standardized extract. The practical considerations are form choice (KSM-66 vs Sensoril vs generic), timing (evening preferred for sleep, AM + PM split for stress/strength), and food coadministration.

AspectRecommendation
FrequencyOnce or twice daily. Single evening dose for sleep emphasis; AM + PM split for stress/cortisol modulation across the day; PM-only for users who find AM dosing produces unwanted drowsiness.
Best time of dayEvening is the practical default — leverages cortisol-reduction at bedtime cortisol-rise window and supports sleep-architecture effects. Unlike Rhodiola (must be morning), ashwagandha is evening-friendly.
FoodWith food preferred — reduces occasional GI discomfort and may improve withanolide absorption. Dinner timing aligns with the evening-dosing protocol.
FormKSM-66 (Ixoreal, root-only, 5% withanolides) — most-studied branded extract; default choice. Sensoril (Natreon, root + leaf, 10% withanolides) — stronger cortisol effect, slight liver-signal awareness. Avoid unstandardized generic ashwagandha extracts.
Standardization markerLook for “KSM-66” or “Sensoril” explicitly on the label. Or alternatively “standardized to 5%+ withanolides, root-only extract.” Third-party tested for withanolide content is the secondary screen.
CyclingOptional. Chronic daily use is well-tolerated in trials extending to 12+ weeks. Some practitioners cycle 8 weeks on / 2 weeks off to assess subjective benefit during washout. No clear tolerance development documented.

What does ashwagandha stack with?

Ashwagandha pairs naturally with the broader stress, GH-axis, and recovery toolkit. The cortisol-reduction + GABA-modulating mechanism complements GH-stimulating peptides, other adaptogens, and sleep-architecture supplements. The three areas below cover the natural stacking categories.

With peptides

Ashwagandha pairs naturally with the growth-hormone-axis peptide cluster — this is audit pairing #3, one of the highest-leverage bidirectional cross-links in the wave spec. CJC-1295 (GHRH analog) and Ipamorelin (ghrelin mimetic / selective GH secretagogue) directly stimulate pituitary GH release. Sermorelin offers a third GHRH-axis option. Ashwagandha operates at complementary layers: cortisol reduction (chronically elevated cortisol suppresses endogenous GH pulsatility) + sleep quality improvement (majority of nightly GH release occurs during slow-wave sleep — ashwagandha supports sleep architecture). The peptides do direct GH stimulation; ashwagandha optimizes the cortisol + sleep environment GH release depends on. Mechanistically complementary, no known negative interactions. The natural-supplement-meets-peptide stack is mature: peptides drive acute GH release; ashwagandha makes endogenous GH pulsatility more efficient.

With supplements

  1. Rhodiola rosea — complementary adaptogen profile. Rhodiola is mildly stimulating (morning use); ashwagandha is calming (evening use). The AM + PM combination provides balanced stress modulation across the day.
  2. ZMA — zinc + magnesium + B6 for sleep architecture + mineral repletion. Standard GH-stack co-occupant; complementary mechanism arms.
  3. L-theanine — alpha-wave calm focus, GABAergic enhancement. Compatible cognitive-calming pairing.
  4. Magnesium glycinate — GABAergic and neuromuscular relaxation. Complementary calming + recovery pairing.
  5. GABA — direct GABAergic supplementation. Mechanism overlap with ashwagandha's GABA-mimetic activity; compatible.
  6. Fenugreek — testosterone-axis adjunct via different mechanism (aromatase + 5-AR inhibition). Common testosterone-stack co-occupant.
  7. Phosphatidylserine — acute cortisol-blunting around exercise. Pairs with ashwagandha's chronic cortisol modulation.

With lifestyle

  1. Resistance training. Ashwagandha's strength-training-adjunct effect (Wankhede 2015, Ziegenfuss 2018) requires consistent training stimulus. Pair with progressive resistance training for the documented gains.
  2. Consistent sleep schedule. Ashwagandha supports sleep quality; sleep optimization supports the GH-axis and cortisol-recovery contexts ashwagandha operates within. Both matter.
  3. Evening dosing with dinner. Aligns the cortisol-reduction effect with the bedtime cortisol-rise window and the slow-wave sleep architecture window where most nightly GH is released.
  4. Thyroid panel before starting. If you have any thyroid concerns or family history. Ashwagandha modestly raises thyroid hormones — beneficial in subclinical hypothyroidism, problematic in hyperthyroid or thyroid-medicated contexts.
  5. Chronic stress contexts. Burnout, high-volume training, sleep-deprived periods — ashwagandha effects are biggest in these populations where cortisol is the limiting factor.
  6. Avoid combining with alcohol or sedatives. Additive sedation possible at high doses via GABA-mimetic activity.

Side effects and interactions

Ashwagandha is well-tolerated in the deep trial base. The main practical considerations are mild GI/drowsiness effects, thyroid hormone modulation (relevant for thyroid-medicated users), rare liver injury reports at very high doses, and pregnancy contraindication.

Common (mostly transient)

  1. Mild GI discomfort — occasional, generally at higher doses or on empty stomach. Resolves with food coadministration.
  2. Drowsiness — intentional for evening use; undesirable if dosed too early. Switch to evening-only dosing if affected during daytime.
  3. Mild GI upset (nausea, loose stools) — uncommon, dose-related.
  4. No documented serious adverse events at standard supplemental doses across the deep RCT base.

Less common (watch-list)

  1. Thyroid hormone elevation. Modestly raises T4 and T3 — beneficial in subclinical hypothyroidism but problematic in hyperthyroid or thyroid-medicated users. Monitor TSH/free T4 every 6–8 weeks if combined with thyroid medication.
  2. Rare liver injury at very high doses. Case reports in 2020–2023 medical literature flag occasional hepatotoxicity at 1,500+ mg/day chronic use. Stay within trial-validated 300–600 mg/day range; choose root-only KSM-66 over root + leaf Sensoril if liver concerns; avoid combining with hepatotoxic agents.
  3. Pregnancy contraindication. Traditional use as uterine stimulant in Ayurveda; theoretical risk of triggering contractions. Avoid during pregnancy.
  4. Hyperthyroidism / Graves disease — can worsen thyrotoxicosis by adding to thyroid hormone load. Avoid.
  5. Autoimmune conditions (Hashimoto's, lupus, MS) — theoretical immune-modulation concerns. Coordinate with specialist.
  6. Solanaceae (nightshade family) allergies — ashwagandha is in the nightshade family. Cross-reactivity possible.

Drug and supplement interactions

  1. Thyroid medication (levothyroxine, T3). Ashwagandha modestly raises endogenous thyroid hormones; may require thyroid medication dose reduction. Monitor TSH/free T4 every 6–8 weeks; coordinate with prescribing clinician.
  2. Sedatives (benzodiazepines, Z-drugs). Additive sedation via GABA-mimetic mechanism. Avoid combining; coordinate with prescribing clinician if needed.
  3. Antihypertensive medications. Mild additive BP-lowering effect. Monitor BP during titration.
  4. Immunosuppressants. Theoretical immune-modulation interaction. Coordinate with specialist for organ transplant or autoimmune contexts.
  5. Diabetes medications — mild glucose-lowering documented. Monitor glucose if combined with insulin/sulfonylureas.
  6. Pregnancy and breastfeeding — avoid. Uterine-stimulant traditional use.

What we don't know yet about ashwagandha

Ashwagandha has one of the deeper adaptogen evidence bases but several open questions affect how confidently it can be recommended in specific contexts.

Testosterone effect in young replete untrained men. The strongest testosterone evidence (Wankhede 2015) is in resistance-trained men, with the effect partly mediated by cortisol-suppression relief. In young healthy untrained men with normal cortisol, the testosterone effect is smaller and less directly demonstrated. The ZMA-pattern concern is real but ashwagandha's evidence base is meaningfully stronger — context-dependent rather than refuted.

Liver injury signal magnitude. Case reports of hepatotoxicity at very high doses (1,500+ mg/day chronic) have emerged in 2020–2023 medical literature. The frequency in typical supplemental users isn't well-quantified. Most users tolerate without liver issues, but the signal isn't zero. Cautious users may want annual liver-enzyme monitoring for long-term high-dose use.

KSM-66 vs Sensoril vs other formulations. KSM-66 (root-only) and Sensoril (root + leaf) have somewhat different bioactive profiles and clinical-trial evidence. Whether other branded extracts (Shoden, Withania Plus, etc.) produce equivalent effects is mechanistically reasonable but not directly head-to-head tested at scale.

Multi-year safety. Most trials extend to 8–16 weeks. Multi-year continuous use is reasonable based on traditional Ayurvedic safety precedent (3,000+ years of use) but not directly RCT-characterized at modern supplemental doses.

Effect on hyperthyroid / autoimmune populations. Ashwagandha can theoretically worsen hyperthyroidism (additive thyroid hormone effect) and may modulate immune function in autoimmune contexts. Clinical safety data in these populations is limited; the conservative recommendation is to avoid without specialist coordination.

Cognitive effects in healthy adults. Cognitive evidence is modest and primarily in stressed/older adult populations. Whether ashwagandha produces meaningful cognitive enhancement in healthy young adults beyond the stress-reduction-mediated effects is less directly supported.

Female-specific use cases. Most evidence is in men; female trials are increasing but smaller. Effects on female testosterone, fertility, menstrual cycle, and menopausal symptoms are emerging but not as deeply characterized.

Where to buy ashwagandha

Ashwagandha is widely available, but product quality varies — branded extracts (KSM-66, Sensoril) have stronger clinical evidence than unstandardized generic ashwagandha. The screen below is what we use before clicking through.

Quality markers to look for

  • KSM-66 (Ixoreal Biomed) — most-studied branded extract; root-only, 5% withanolides. Default choice for general adaptogen / testosterone / strength applications.
  • Sensoril (Natreon) — root + leaf, 10% withanolides. Stronger cortisol-reduction effect; slight liver-signal awareness from the leaf component.
  • Standardized to 5%+ withanolides if neither KSM-66 nor Sensoril branding — explicit withanolide content disclosure is the central quality marker.
  • Root-only extract preferred for liver-cautious users — root + leaf preparations have a slight elevation in case reports.
  • Third-party tested — USP, NSF, or ConsumerLab certifications. HPLC verification of withanolide content is the relevant additional screen.
  • cGMP-certified manufacturing facility — minimum bar for any supplement.
  • No proprietary stress / testosterone blends that obscure the actual ashwagandha dose alongside other ingredients.
  • Avoid unstandardized generic ashwagandha — withanolide content can range from 1–5% with significant batch variability.
Shop Ashwagandha on Amazon →

Amazon affiliate link — Prof. Peptide earns a small commission on qualifying purchases at no extra cost to you. We use commissions to fund research and editorial work.

Ashwagandha FAQ

KSM-66 vs Sensoril vs generic ashwagandha — which form?

KSM-66 (Ixoreal Biomed) is the most-studied branded extract — full-spectrum root extract standardized to 5% withanolides, used in most positive RCTs (Wankhede 2015 testosterone, Lopresti 2019, sleep trials). Sensoril (Natreon) is root + leaf, standardized to 10% withanolides — produces stronger cortisol-reduction and stress-relief effects per some trials but uses a different bioactive profile. Generic 'ashwagandha extract' without standardization disclosure may underperform at the same labeled dose. Practical heuristic: KSM-66 for testosterone/strength/general adaptogen use; Sensoril for primary anxiety/cortisol-reduction goal; avoid unstandardized generic products. Look for KSM-66 or Sensoril explicitly on the label.

Does ashwagandha really raise testosterone?

Yes, with context-dependent effect sizes — different from ZMA where the testosterone claim has been refuted. The Wankhede 2015 KSM-66 trial in resistance-trained men documented significant testosterone increases (96 ng/dL vs 18 ng/dL placebo) over 8 weeks. Lopresti 2019 in overweight men aged 40–70 documented testosterone and DHEA-S increases over 16 weeks. The honest framing: the testosterone effect is real in stressed, training-loaded, sleep-disrupted, or hypogonadal populations where cortisol-mediated suppression of testosterone is the limiting factor — ashwagandha relieves this suppression. In replete healthy young untrained men with normal cortisol, the effect is smaller. Not equivalent to TRT or clomiphene; modest endogenous testosterone support that's most useful when cortisol is the bottleneck.

What's the right ashwagandha dose?

300–600 mg/day of standardized extract (KSM-66 5% withanolides or Sensoril 10% withanolides). Wankhede 2015 used 300 mg KSM-66 twice daily; Chandrasekhar 2012 used 300 mg twice daily for stress; Lopresti 2019 used 600 mg/day; Salve 2019 sleep trial used 600 mg/day. Practical default: 600 mg/day total, split as 300 mg AM + 300 mg PM, or single PM dose for sleep emphasis. Higher doses (1,000+ mg) don't clearly add benefit and may increase GI effects. Take with food for better tolerance.

Does ashwagandha actually help with sleep?

Yes, with reasonable evidence. Salve 2019 (60 days, 600 mg/day) documented significant sleep quality improvements (Pittsburgh Sleep Quality Index) in adults with insomnia. Multiple smaller trials confirm the directional signal. Mechanism likely involves GABA-mimetic effects (withanolides bind GABA receptors) plus cortisol-mediated arousal reduction (chronic cortisol elevation impairs sleep architecture). Useful for users whose sleep is blocked by stress-related arousal. Effect builds over 2–4 weeks of consistent evening dosing — not an acute sleep aid like melatonin.

Can I stack ashwagandha with CJC-1295 or Ipamorelin?

Yes — and the stack is mechanistically natural for users targeting comprehensive GH-axis and recovery support. This is audit pairing #3 (highest-leverage GH-axis bidirectional cross-link). CJC-1295 (GHRH analog) and Ipamorelin (ghrelin mimetic / selective GH secretagogue) directly stimulate pituitary GH release. Sermorelin is a third GHRH-axis option. Ashwagandha operates at a different layer: cortisol reduction (chronically elevated cortisol suppresses GH pulsatility and growth hormone release) + sleep quality improvement (the majority of nightly GH release occurs during slow-wave sleep — ashwagandha supports sleep architecture). The peptides do direct GH stimulation; ashwagandha optimizes the cortisol + sleep environment GH release depends on. Mechanistically complementary, no known negative interactions. One of the more mechanistically coherent natural-supplement-meets-peptide stacks.

Are there any thyroid concerns with ashwagandha?

Yes — be careful in two scenarios. (1) Subclinical hypothyroidism: ashwagandha modestly raises T4 and T3 in this population (Sharma 2018), which can be beneficial if you have low thyroid function but problematic if you're already on thyroid medication. (2) Hyperthyroidism or Graves' disease: ashwagandha can theoretically worsen thyrotoxicosis by adding to thyroid hormone load — avoid in this context. (3) Hashimoto's autoimmune thyroiditis: theoretical concern about immune modulation; coordinate with endocrinologist. Practical rule: get thyroid panel before starting if you have any thyroid concerns, and monitor TSH/free T4/free T3 every 6–8 weeks if combining with thyroid medication.

Should I take ashwagandha in the morning or evening?

Evening is the practical default for most users — leverages the sleep-quality improvement and cortisol-reduction mechanism. The Salve 2019 sleep trial used evening dosing. Morning dosing is reasonable if your primary goal is daytime stress modulation or if evening doses produce unwanted next-day drowsiness in sensitive users. Split AM + PM is the highest-evidence protocol (Wankhede 2015 testosterone trial used 300 mg twice daily). Unlike Rhodiola which must be morning-only, ashwagandha is calming-leaning and evening-friendly.

Does ashwagandha have liver concerns?

Rare reports of liver injury at very high doses (1,500+ mg/day chronic) — flagged by case reports in 2020–2023 medical literature. Modest signal at typical supplemental doses but worth awareness. Practical mitigations: stay within trial-validated 300–600 mg/day range; choose root-only extracts (KSM-66) rather than root + leaf (Sensoril) given the leaf component is more associated with hepatic concerns in some case reports; avoid combining with other hepatotoxic agents (alcohol, acetaminophen high doses); monitor liver enzymes annually if using long-term at higher doses. The vast majority of users tolerate ashwagandha without liver issues, but the signal isn't zero.

References

  1. Chandrasekhar K, Kapoor J, Anishetty S. A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian J Psychol Med. 2012;34(3):255-262. https://pubmed.ncbi.nlm.nih.gov/23439798/
  2. Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S. Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. J Int Soc Sports Nutr. 2015;12:43. https://pubmed.ncbi.nlm.nih.gov/26609282/
  3. Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: a randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019;98(37):e17186. https://pubmed.ncbi.nlm.nih.gov/31517876/
  4. Ziegenfuss TN, Kedia AW, Sandrock JE, Raub BJ, Kerksick CM, Lopez HL. Effects of an aqueous extract of Withania somnifera on strength training adaptations and recovery: the STAR trial. Nutrients. 2018;10(11):1807. https://pubmed.ncbi.nlm.nih.gov/30463324/
  5. Salve J, Pate S, Debnath K, Langade D. Adaptogenic and anxiolytic effects of ashwagandha root extract in healthy adults: a double-blind, randomized, placebo-controlled clinical study. Cureus. 2019;11(12):e6466. https://pubmed.ncbi.nlm.nih.gov/32021735/
  6. Pratte MA, Nanavati KB, Young V, Morley CP. An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). J Altern Complement Med. 2014;20(12):901-908. https://pubmed.ncbi.nlm.nih.gov/25405876/

Published Studies

Plain-English summaries of the peer-reviewed studies behind the claims above. Click any title to read the source paper.

Indian Journal of Psychological Medicine · 2012Open Access
A Prospective, Randomized Double-Blind, Placebo-Controlled Study of Safety and Efficacy of a High-Concentration Full-Spectrum Extract of Ashwagandha Root in Reducing Stress and Anxiety in Adults →

Chandrasekhar K, Kapoor J, Anishetty S

A 60-day randomized double-blind placebo-controlled trial of 300 mg ashwagandha root extract twice daily (KSM-66 precursor formulation) in 64 adults with chronic stress. Ashwagandha significantly reduced perceived stress scale scores (-44% vs -5.5% placebo) and serum cortisol (-27.9% vs -7.9% placebo) versus placebo. The Chandrasekhar 2012 trial is the foundational human evidence for ashwagandha's cortisol-reduction and anti-stress effects and the basis for the chronic-use protocol.

Journal of the International Society of Sports Nutrition · 2015Open Access
Examining the Effect of Withania somnifera Supplementation on Muscle Strength and Recovery: A Randomized Controlled Trial →

Wankhede S, Langade D, Joshi K, Sinha SR, Bhattacharyya S

An 8-week randomized double-blind placebo-controlled trial of 300 mg KSM-66 ashwagandha twice daily in 57 healthy resistance-trained men. KSM-66 significantly increased bench press (+18.2 kg vs +6.1 kg placebo), leg extension strength, muscle size (arm and chest circumference), and testosterone (+96 ng/dL vs +18 ng/dL placebo), while reducing exercise-induced muscle damage. The Wankhede 2015 KSM-66 trial is the foundational evidence for ashwagandha in resistance-training contexts and the most-cited reference for the testosterone-elevation claim.

Medicine (Baltimore) · 2019Open Access
An Investigation into the Stress-Relieving and Pharmacological Actions of an Ashwagandha (Withania somnifera) Extract: A Randomized, Double-Blind, Placebo-Controlled Study →

Lopresti AL, Smith SJ, Malvi H, Kodgule R

An 8-week randomized double-blind placebo-controlled trial of 240 mg Shoden ashwagandha extract in 60 stressed adults. Ashwagandha significantly reduced morning cortisol (-22.2% vs -8.5% placebo) and DHEA-S, reduced perceived stress, and improved sleep quality versus placebo. Replicates Chandrasekhar 2012 findings with a different branded extract — supporting the cortisol-and-stress mechanism arm across formulations.

Nutrients · 2018Open Access
Effects of Ashwagandha (Withania somnifera) on Strength Training Adaptations and Recovery: The STAR Trial →

Ziegenfuss TN, Kedia AW, Sandrock JE, Raub BJ, Kerksick CM, Lopez HL

A 12-week randomized double-blind placebo-controlled trial of Sensoril ashwagandha (500 mg/day) in 38 recreationally active adults during a structured resistance training program. Ashwagandha significantly improved squat and bench press strength, vertical jump, and reduced exercise-induced muscle damage versus placebo. The STAR trial replicates and extends Wankhede 2015 with a different branded extract and longer duration — supporting ashwagandha as a strength-training adjunct beyond the testosterone-specific arm.

Cureus · 2019Open Access
Adaptogenic and Anxiolytic Effects of Ashwagandha Root Extract in Healthy Adults: A Double-Blind, Randomized, Placebo-Controlled Clinical Study →

Salve J, Pate S, Debnath K, Langade D

An 8-week randomized double-blind placebo-controlled trial of 240–600 mg KSM-66 ashwagandha in 60 adults with insomnia. Higher dose (600 mg) significantly improved sleep quality (Pittsburgh Sleep Quality Index) and reduced anxiety and stress versus placebo. The Salve 2019 trial is the cleanest evidence for ashwagandha's sleep effects and supports the evening-dosing protocol for sleep-focused use cases.

AdaptogenCortisolTestosteroneKSM-66HPA AxisSleep

Related Supplements

Rhodiola RoseaZMAL-TheanineMagnesiumFenugreekPhosphatidylserine

We may earn commissions from peptide vendor affiliate links.

Have a question about Ashwagandha? Send us an email →